In nonadvanced PD patients, the PET scan employing [18F] FE-PE2I has been shown to enable accurate assessment of the DAT deficit in several nigrostriatal areas, offering important insights into the course and severity of the disease. The gene discussed is SLC6A3; the disease is Parkinson disease.